What's New with Roche Pathology Lab

First FDA-approved IHC companion diagnostic for determining MET protein expression in patients with NSQ-NSCLC eligible for treatment with Emrelis^™.

Like you, we’re passionate about the patient behind every slide. We’re committed to transforming cancer diagnosis with solutions that address the needs of anatomic pathology labs and healthcare professionals to help them improve the lives of the patients they serve. Our broad portfolio includes VENTANA integrated staining and workflow management platforms, digital pathology solutions and a robust menu of high-medical value assays that help labs increase efficiency, improve patient safety and deliver medical value.

PATHWAY anti-HER2/neu (4B5) Rabbit Monoclonal Primary Antibody is now FDA-approved for patients with HER2-ultralow levels of expression who may benefit from targeted treatment.

Provide multiple therapy options with one MMR CDx IHC panel.

The VENTANA^® Kappa and Lambda Dual ISH mRNA Probe Cocktail is a dual color assay that enables clonality assessment in all B-cell lymphoma subtypes and plasma cell neoplasms.

INSM1 (SP493) Rabbit Monoclonal Primary Antibody is intended for laboratory use in the qualitative immunohistochemical detection of INSM1 protein by light microscopy in sections of formalin-fixed, paraffinembedded tissue stained on a BenchMark IHC/ISH instrument.

Innovative HER2 testing is elevating hope for patients with Biliary Tract Cancer (BTC) that has progressed after first-line therapy. There is a significant unmet need for targeted therapies that can potentially improve survival.

CD68 (SP251v18) Rabbit Monoclonal Antibody is intended for laboratory use in the qualitative immunohistochemical detection of CD68 by light microscopy in sections of formalin -fixed, paraffin- embedded tissue stained on a BenchMark IHC/ISH instrument.

Join us at Pathology Visions 2025 to learn more about how we're bringing innovation to the lab.

Join us at NSH to see how we're breaking down barriers in the lab.

Join us at CAP 2025 to learn how labs can leverage digital pathology solutions to deliver accurate and timely results to improve patient care.

Watch this webinar on demand to explore the nuances of HER2 IHC expression, understand the role of in situ-hybridization, and uncover the benefits of AI-powered scoring and assessment techniques.

In this on-demand webinar, Dr. Eric Walk will guide you through the fundamentals of artificial intelligence and machine learning (AI/ML), demystify key concepts, and explore how these technologies are being tailored to real-world applications in pathology practice and precision medicine.

This session will give you the tools to unlock the benefits of digital pathology for your healthcare organization and your patients. 

During this webinar, you will hear from a pathologist who has adopted digital pathology and will share his experiences, insights, and considerations when choosing a digital pathology system.

In this session, you learn about artificial intelligence (AI) and machine learning (ML) in the development of image analysis tools for digital pathology, and understand current AI/ML methods and how they address the different aspects of AI development